Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging
نویسندگان
چکیده
Abstract Background Radiomics is a promising tool for identifying imaging-based biomarkers. Radiomics-based models are often trained on single-institution datasets; however, multi-centre imaging datasets preferred external generalizability owing to the influence of inter-institutional scanning differences and acquisition settings. The study aim was determine value preselection robust radiomic features in routine clinical positron emission tomography (PET) images predict outcomes locally advanced non-small cell lung cancer (NSCLC). Methods A total 1404 primary tumour were extracted from pre-treatment [ 18 F]fluorodeoxyglucose (FDG)-PET scans stage IIIA/N2 or IIIB NSCLC patients using training cohort ( n = 79; prospective Swiss randomized phase III trial SAKK 16/00; 16 centres) an internal validation 31; single centre). Robustness studies investigating delineation variation, attenuation correction motion performed (intraclass correlation coefficient threshold > 0.9). Two 12-/24-month event-free survival (EFS) overall (OS) logistic regression standardized imaging: (1) with alone (2) all available features. Models then validated fivefold cross-validation, separate single-centre dataset. Model performance assessed area under receiver operating characteristic curve (AUC). Results identified 179 stable (13%), 25% 3D versus 4D acquisition, 31% 78% delineation. Univariable analysis found no significant predicting EFS 12-month OS p 0.076). Prognostic without well (AUC 0.73) 0.74). Patient stratification into two risk groups based 0.02) cohorts 0.03). Conclusions PET-based radiomics model standardized, dataset successfully established good performance. Prediction feature unsuccessful, indicating need protocol.
منابع مشابه
FDG-PET and CT features of non-small cell lung cancer based on tumor type.
We determined if specific tumor types of non-small cell lung cancer can be identified by variance in FDG-PET standard uptake value (SUV) in combination with characteristics on CT. Staging FDG-PET and CT scans of 81 patients (34 men and 47 women, average age 67+/-11 years) with 82 lung cancers were analyzed. Mean tumor SUV was calculated at the location of maximum FDG uptake. Tumor size, margins...
متن کاملA Prospective Study Comparing Functional Imaging (18F-FDG PET) Versus Anatomical Imaging (Contrast Enhanced CT) in Dosimetric Planning for Non-small Cell Lung Cancer.
Objective(s): 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET-CT) is a well-used and established technique for lung cancer staging. Radiation therapy requires accurate target volume delineation, which is difficult in most cases due to coexisting atelectasis. The present study was performed to compare the 18F-FDG PET-CT with contrast enhanced computed tomogr...
متن کاملTriage of Limited Versus Extensive Disease on 18F-FDG PET/CT Scan in Small Cell lung Cancer
Objective(s): Small cell lung cancer (SCLC) is an aggressive neuroendocrine carcinoma, which accounts for 10-15% of pulmonary cancers and exhibits early metastatic spread. This study aimed to determine the added value of 18F-FDG PET/CT imaging in tumor, node, and metastasis (TNM) staging of SCLC, compared to the conventional computed tomography (CT) scan and its potential role as a prognosticat...
متن کاملClinicopathological Features of Patients with Non-small-cell Lung Cancer in West of Iran
Background: Lung cancer is the most common cause of cancer death worldwide with an annual mortality rate of more than 1.3 million worldwide. We aimed to analyze the clinicopathological features of patients with non-small-cell lung cancer (NSCLC) in west of Iran. Methods: 64 patients with NSCLC who referred to our clinic were analyzed. Sex, age, histopathology, location of the tumor, treatment,...
متن کاملFDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer.
Objective of this work was to evaluate the role of 18F-fluorodeoxyglucose (FDG) positron-emission tomography features as theranostic imaging biomarkers in non-small cell lung cancer. In a retrospective protocol, 31 stage I-III NSCLC patients were enrolled. Patients underwent FDG PET/CT for staging purposes before surgery and were followed for two years after surgery. PET images were quantitativ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: EJNMMI research
سال: 2021
ISSN: ['2191-219X']
DOI: https://doi.org/10.1186/s13550-021-00809-3